The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study

被引：0

作者：

Akito Nozaki

Masanori Atsukawa

Chisa Kondo

Hidenori Toyoda

Makoto Chuma

Makoto Nakamuta

Haruki Uojima

Koichi Takaguchi

Hiroki Ikeda

Tsunamasa Watanabe

Shintaro Ogawa

Norio Itokawa

Taeang Arai

Atsushi Hiraoka

Toru Asano

Shinichi Fujioka

Tadashi Ikegami

Toshihide Shima

Chikara Ogawa

Takehiro Akahane

Noritomo Shimada

Shinya Fukunishi

Hiroshi Abe

Akihito Tsubota

Takuya Genda

Hironao Okubo

Shigeru Mikami

Asahiro Morishita

Akio Moriya

Joji Tani

Yoshihiko Tachi

Naoki Hotta

Toru Ishikawa

Takeshi Okanoue

Yasuhito Tanaka

Takashi Kumada

Katsuhiko Iwakiri

Shin Maeda

机构：

[1] Yokohama City University Medical Center,Gastroenterological Center

[2] Nippon Medical School,Department of Internal Medicine, Division of Gastroenterology and Hepatology

[3] Ogaki Municipal Hospital,Department of Gastroenterology

[4] National Hospital Organization Kyushu Medical Center,Department of Gastroenterology, Internal Medicine

[5] Kitasato University School of Medicine,Department of Hepatology

[6] Kagawa Prefectural Central Hospital,Department of Internal Medicine

[7] St. Marianna University School of Medicine,Department of Virology and Liver Unit

[8] Nagoya City University,Division of Gastroenterology, Department of Internal Medicine

[9] Graduate School of Medical Sciences,Division of Gastroenterology, Department of Internal Medicine

[10] Nippon Medical School Chiba Hokusoh Hospital,Gastroenterology Center

[11] Nippon Medical School Musashikosugi Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[12] Ehime Prefectural Central Hospital,Department of Gastroenterology

[13] Tokyo Metropolitan Bokutoh Hospital,Department of Gastroenterology and Hepatology

[14] Okayama Saiseikai General Hospital,Department of Gastroenterology and Hepatology

[15] Tokyo Medical University Ibaraki Medical Center,Department of Gastroenterology

[16] Saiseikai Suita Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[17] Takamatsu Red Cross Hospital,Second Department of Internal Medicine

[18] Japanese Red Cross Ishinomaki Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[19] Otakanomori Hospital,Core Research Facilities for Basic Science

[20] Osaka Medical College,Department of Gastroenterology

[21] Shinmatsudo Central General Hospital,Department of Gastroenterology

[22] The Jikei University School of Medicine,Division of Gastroenterology, Department of Internal Medicine

[23] Juntendo Shizuoka University Hospital,Department of Gastroenterology

[24] Juntendo Nerima University Hospital,Department of Gastroenterology

[25] Kikkoman General Hospital,Department of Internal Medicine

[26] Kagawa University Graduate School of Medicine,Division of Hepatology, Department of Internal Medicine

[27] Mitoyo General Hospital,Department of Hepatology

[28] Yashima General Hospital,Department of Gastroenterology

[29] Bantane Hospital,undefined

[30] Fujita Health University School of Medicine,undefined

[31] Masuko Memorial Hospital,undefined

[32] Saiseikai Niigata Daini Hospital,undefined

[33] Yokohama City University Graduate School of Medicine,undefined

来源：

Hepatology International | 2020年 / 14卷

关键词：

Glecaprevir; Pibrentasvir; Chronic hepatitis C; Refractory factors; Multicenter study;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：225 / 238

页数：13

共 50 条

[41] Efficacy and safety of glecaprevir/pibrentasvir as retreatment therapy for patients with genotype 2 chronic hepatitis C who failed prior sofosbuvir plus ribavirin regimen [J].

Kusakabe, Atsunori ;

Kurosaki, Masayuki ;

Itakura, Jun ;

Joko, Kouji ;

Akahane, Takehiro ;

Tsuji, Keiji ;

Kobashi, Haruhiko ;

Sohda, Tetsuro ;

Kimura, Hiroyuki ;

Narita, Ryouichi ;

Furuta, Koichirou ;

Izumi, Namiki .

HEPATOLOGY RESEARCH, 2019, 49 (10) :1121-1126

[42] Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection [J].

Goki Suda ;

Chitomi Hasebe ;

Masami Abe ;

Masayuki Kurosaki ;

Jun Itakura ;

Namiki Izumi ;

Yoshihito Uchida ;

Satoshi Mochida ;

Hiroaki Haga ;

Yoshiyuki Ueno ;

Kazumichi Abe ;

Atsushi Takahashi ;

Hiromasa Ohira ;

Yoko Tsukuda ;

Ken Furuya ;

Masaru Baba ;

Yoshiya Yamamoto ;

Tomoe Kobayashi ;

Jun Inoue ;

Katsumi Terasita ;

Masatsugu Ohara ;

Naoki Kawagishi ;

Takaaki Izumi ;

Masato Nakai ;

Takuya Sho ;

Mitsuteru Natsuizaka ;

Kenichi Morikawa ;

Koji Ogawa ;

Naoya Sakamoto .

Journal of Gastroenterology, 2019, 54 :641-649

[43] Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures [J].

Mitsutaka Osawa ;

Michio Imamura ;

Yuji Teraoka ;

Takuro Uchida ;

Kei Morio ;

Hatsue Fujino ;

Takashi Nakahara ;

Atsushi Ono ;

Eisuke Murakami ;

Tomokazu Kawaoka ;

Daiki Miki ;

Masataka Tsuge ;

Akira Hiramatsu ;

Hiroshi Aikata ;

C. Nelson Hayes ;

Kazuaki Chayama .

Journal of Gastroenterology, 2019, 54 :291-296

[44] Real-world experience of 12-week direct-acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection [J].

Toyoda, Hidenori ;

Atsukawa, Masanori ;

Watanabe, Tsunamasa ;

Nakamuta, Makoto ;

Uojima, Haruki ;

Nozaki, Akito ;

Takaguchi, Koichi ;

Fujioka, Shinichi ;

Iio, Etsuko ;

Shima, Toshihide ;

Akahane, Takehiro ;

Fukunishi, Shinya ;

Asano, Toru ;

Michitaka, Kojiro ;

Tsuji, Kunihiko ;

Abe, Hiroshi ;

Mikami, Shigeru ;

Okubo, Hironao ;

Okubo, Tomomi ;

Shimada, Noritomo ;

Ishikawa, Toru ;

Moriya, Akio ;

Tani, Joji ;

Morishita, Asahiro ;

Ogawa, Chikara ;

Tachi, Yoshihiko ;

Ikeda, Hiroki ;

Yamashita, Naoki ;

Yasuda, Satoshi ;

Chuma, Makoto ;

Tsutsui, Akemi ;

Hiraoka, Atsushi ;

Ikegami, Tadashi ;

Genda, Takuya ;

Tsubota, Akihito ;

Masaki, Tsutomu ;

Tanaka, Yasuhito ;

Iwakiri, Katsuhiko ;

Kumada, Takashi .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (05) :855-861

[45] Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection [J].

Suda, Goki ;

Hasebe, Chitomi ;

Abe, Masami ;

Kurosaki, Masayuki ;

Itakura, Jun ;

Izumi, Namiki ;

Uchida, Yoshihito ;

Mochida, Satoshi ;

Haga, Hiroaki ;

Ueno, Yoshiyuki ;

Abe, Kazumichi ;

Takahashi, Atsushi ;

Ohira, Hiromasa ;

Tsukuda, Yoko ;

Furuya, Ken ;

Baba, Masaru ;

Yamamoto, Yoshiya ;

Kobayashi, Tomoe ;

Inoue, Jun ;

Terasita, Katsumi ;

Ohara, Masatsugu ;

Kawagishi, Naoki ;

Izumi, Takaaki ;

Nakai, Masato ;

Sho, Takuya ;

Natsuizaka, Mitsuteru ;

Morikawa, Kenichi ;

Ogawa, Koji ;

Sakamoto, Naoya ;

Yoshida, Junichi ;

Nagasaka, Atsushi ;

Fuzinaga, Akira ;

Kikuchi, Hideaki ;

Atarashi, Tomofumi ;

Furuya, Ken ;

Muto, Shuichi ;

Meguro, Takashi ;

Saga, Akiyoshi ;

Okamoto, Munenori ;

Katagiri, Masaki ;

Miyagishima, Takuto ;

Konno, Jun ;

Kumagai, Kenichi ;

Onodera, Manabu ;

Kobayashi, Tomoe ;

Uebayashi, Minoru ;

Katou, Kanji ;

Kunieda, Yasuyuki ;

Tateyama, Miki ;

Kawakami, Atsuhiko .

JOURNAL OF GASTROENTEROLOGY, 2019, 54 (07) :641-649

[46] Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study [J].

Pugliese, Nicola ;

Calvaruso, Vincenza ;

Masarone, Mario ;

D'Ambrosio, Roberta ;

Battistella, Sara ;

Licata, Anna ;

Persico, Marcello ;

Anolli, Maria Paola ;

Distefano, Marco ;

Petta, Salvatore ;

Russo, Francesco Paolo ;

Di Marco, Vito ;

Aghemo, Alessio .

LIVER INTERNATIONAL, 2023, 43 (07) :1440-1445

[47] Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real-world experience? [J].

Zarebska-Michaluk, Dorota ;

Jaroszewicz, Jerzy ;

Pabjan, Pawel ;

Lapinski, Tadeusz W. ;

Mazur, Wlodzimierz ;

Krygier, Rafal ;

Dybowska, Dorota ;

Halota, Waldemar ;

Pawlowska, Malgorzata ;

Janczewska, Ewa ;

Buczynska, Iwona ;

Simon, Krzysztof ;

Dobracka, Beata ;

Citko, Jolanta ;

Laurans, Lukasz ;

Tudrujek-Zdunek, Magdalena ;

Tomasiewicz, Krzysztof ;

Piekarska, Anna ;

Sitko, Marek ;

Bialkowska-Warzecha, Jolanta ;

Klapaczynski, Jakub ;

Sobala-Szczygiel, Barbara ;

Horban, Andrzej ;

Berak, Hanna ;

Deron, Zbigniew ;

Lorenc, Beata ;

Socha, Lukasz ;

Tronina, Olga ;

Flisiak, Robert .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (07) :1944-1952

[48] Efficacy and safety of Glecaprevir/Pibrentasvir in the treatment of mixed cryo-globulinemia due to chronic hepatitis C cirrhosis in a patient with chronic kidney disease [J].

Papadopoulos, N. ;

Flouda, S. ;

Sveroni, E. ;

Palla, Tatarida M. C. ;

German, V .

HIPPOKRATIA, 2019, 23 (01) :30-32

[49] Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures [J].

Osawa, Mitsutaka ;

Imamura, Michio ;

Teraoka, Yuji ;

Uchida, Takuro ;

Morio, Kei ;

Fujino, Hatsue ;

Nakahara, Takashi ;

Ono, Atsushi ;

Murakami, Eisuke ;

Kawaoka, Tomokazu ;

Miki, Daiki ;

Tsuge, Masataka ;

Hiramatsu, Akira ;

Aikata, Hiroshi ;

Hayes, C. Nelson ;

Chayama, Kazuaki ;

Aimitsu, Shiomi ;

Azakami, Takahiro ;

Kamada, Koji ;

Katamura, Yoshio ;

Kawakami, Hiroiku ;

Kawakami, Yoshiiku ;

Kimura, Takashi ;

Takahashi, Shoichi ;

Tsuji, Keiji ;

Takaki, Shintaro ;

Mori, Nami ;

Nagaoki, Yuko ;

Moriya, Takashi ;

Yamaguchi, Shuji .

JOURNAL OF GASTROENTEROLOGY, 2019, 54 (03) :291-296

[50] Efficacy and safety of glecaprevir and pibrentasvir treatment for 8 or 12 weeks in patients with recurrent hepatitis C after liver transplantation: a Japanese multicenter experience [J].

Yoshihide Ueda ;

Tsuyoshi Kobayashi ;

Toru Ikegami ;

Satoshi Miuma ;

Shugo Mizuno ;

Nobuhisa Akamatsu ;

Akinobu Takaki ;

Masatoshi Ishigami ;

Mitsuhisa Takatsuki ;

Yasuhiko Sugawara ;

Yoshihiko Maehara ;

Shinji Uemoto ;

Hiroshi Seno .

Journal of Gastroenterology, 2019, 54 :660-666

← 1 2 3 4 5 →